Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Oncogene|January 11, 2007
Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cellsV Appierto, M G Villani, E Cavadini, et al.
The International Journal of Biological Markers|July 19, 2006
Questioning the utility of pooling samples in microarray experiments with cell linesL Lusa, V Cappelletti, M Gariboldi, et al.
British Journal of Cancer|October 15, 2009
Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesisR Fernández-Ramires, X Solé, L De Cecco, et al.
BMC Genomics|June 7, 2018
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinomaC Peraldo-Neia, P Ostano, G Cavalloni, et al.
Breast Cancer Research and Treatment|April 30, 2024
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTOS Pizzamiglio, C M Ciniselli, E de Azambuja, et al.
ESMO Open|March 20, 2021
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapyE Ortolan, V Appierto, M Silvestri, et al.
NPJ Breast Cancer|December 2, 2025
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapyS Pizzamiglio, A Blanda, V Appierto, et al.
ESMO Open|July 2, 2023
A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancerC Chiodoni, S Sangaletti, M Lecchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2018
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)J-P Machiels, P Bossi, J Menis, et al.
ESMO Open|January 4, 2025
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trialB Pellegrino, E D Capoluongo, M Bagnoli, et al.
Pageof 6